Targeted deletion of hepatocyte Ikkβ confers growth advantages

Katherine S. Koch; Shin Maeda; Guobin He; Michael Karin; Hyam L. Leffert

doi:10.1016/j.bbrc.2009.01.085

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1

Noriko Matsushita, Mohamed Hassanein, Marcos Martínez‐Clemente, Raul Lazaro, Samuel W. French, Wen Xie, Keane K. Y. Lai, Michael Karin, Hidekazu Tsukamoto

Article2005

IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

Shin Maeda, Hideaki Kamata, Jun‐Li Luo, Hyam L. Leffert, Michael Karin

Article2014

Hepatocyte Growth Factor Deficiency in COPD

Peter J Barnes

Article2010

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

Guobin He, Guann‐Yi Yu, Vladislav Temkin, Hisanobu Ogata, Christian Kuntzen, Toshiharu Sakurai, Wolfgang Sieghart, Markus Peck‐Radosavljevic, Hyam L. Leffert, Michael Karin

Article2018

Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice

Jialin Xu, Liya Li, Wang Yan Qing, Yaqi Li, Mu Shan, Shizhuo Sun, Yang Yu, Bing Wang